Effect and safety of Diphteria-Pertussis-Tetanus vaccine among healthcare workers

Effect and safety of Diphteria-Pertussis-Tetanus vaccine among healthcare workers - Effect and safety of DTaP among healthcare workers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021495

Enrollment

150

Registered

2016-03-16

Start date

2015-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Interventions

We examine the study from January 1st, 2014 to January 31th, 2015. We measure antibodies against Pertussis antigen in the eligible person who obtained our consent, thereafter we vaccinate with DTaP wh

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Healthcare worker who work in hospital ward and outpatient department at Children's Medical Center and Perinatal Center, Yokohama City University Medical Center. - Eligible person who obtained our consent. - Age over the 20 years old and under the 65 years old.

Exclusion criteria

Exclusion criteria: - Healthcare worker who had a history of serious side effect from vaccination.

Design outcomes

Primary

Measure	Time frame
We measure antibodies against PT, FHA, Fim2, Fim3, catACT and cFHA using enzyme-linked immunosorbent assay before vaccination, one month and one year after vaccination.	—

Secondary

Measure	Time frame
We carry out a questionnaire survey to examine the safety of vaccination within seven days after administration about the presence of fever, headache, malaise, pain, redness, swelling and sensations of burning.	—

Countries

Japan

Contacts

Public ContactHiroyuki Shimizu

Yokohama City University Medical Center Children's Medical Center

hiroyukiowl@hotmail.co.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026